- Re-focusing on Getting Fit? Heart Experts Offer These Tips
- AHA News: Not Just Bad Shoes and Sore Muscles – She Had Peripheral Artery Disease
- Scientists Find Clues to Why AstraZeneca’s Vaccine May Cause Clots
- Stressed, Exhausted: Frontline Workers Faced Big Mental Strain in Pandemic
- Supply of J&J COVID Vaccine to Drop 86 Percent Next Week
- Health Highlights: April 9, 2021
- Nearly Half of U.S. Veterans Cited ‘Personal Growth’ During Pandemic: Survey
- Obesity May Help Trigger Heavier Periods: Study
- Bright Side: Sunnier Areas Have Lower COVID-19 Death Rates
- Pandemic Has Put Many Clinical Trials on Hold
Clinical Trials Update: Feb. 10, 2010
(HealthDayNews) — Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Type 2 Diabetes
This is a 26-week study to evaluate the effectiveness of an investigational drug in people with type 2 diabetes.
The research site is in Escondido, Calif.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Major Depressive Disorder
If you are aged 18 to 65 and have symptoms of depression, you may qualify for this study of an investigational drug.
The research site is in New York City.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
—–
Rheumatoid Arthritis
If your rheumatoid arthritis symptoms persist despite treatment, you may qualify for this study of an investigational medication.
The research site is in Duncansville, Penn.
More Information
Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
